Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.8753
+0.0635 (7.82%)
At close: May 20, 2026, 4:00 PM EDT
0.8500
-0.0253 (-2.89%)
After-hours: May 20, 2026, 7:54 PM EDT
Valion Bio Market Cap
Valion Bio has a market cap or net worth of $2.75 million as of May 20, 2026. Its market cap has decreased by -0.21% in one year.
Market Cap
2.75M
Enterprise Value
12.37M
1-Year Change
-0.21%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since November 11, 2021, Valion Bio's market cap has decreased from $48.09M to $2.75M, a decrease of -94.29%. That is a compound annual growth rate of -46.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 2.55M | -30.42% |
| Dec 31, 2025 | 3.66M | 11.74% |
| Dec 31, 2024 | 3.28M | 24.20% |
| Dec 29, 2023 | 2.64M | -57.38% |
| Dec 30, 2022 | 6.19M | -83.57% |
| Dec 31, 2021 | 37.69M | -21.62% |
| Nov 11, 2021 | 48.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adial Pharmaceuticals | 3.36M |
| Azitra | 3.19M |
| GRI Bio | 3.18M |
| Decoy Therapeutics | 2.96M |
| Ensysce Biosciences | 2.88M |
| Indaptus Therapeutics | 2.76M |
| Calidi Biotherapeutics | 2.60M |
| Clearmind Medicine | 2.57M |